NasdaqGS - Delayed Quote USD
Prelude Therapeutics Incorporated (PRLD)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 5:02 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BONITA DAVID P. M.D. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | May 22, 2023 | -- |
| CHARDONNET LAURENT Chief Financial Officer | Purchase | May 23, 2023 | 42,165 |
| HUANG JANE President | Conversion of Exercise of derivative security | Oct 4, 2024 | 63,341 |
| LIM BRYANT DAVID Officer | Purchase | May 24, 2023 | 2,400 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | May 22, 2023 | -- |
| VADDI KRISHNA Chief Executive Officer | Purchase | May 25, 2023 | 2,715,140 |
Related Tickers
FHTX Foghorn Therapeutics Inc.
7.23
-5.74%
SNSE Sensei Biotherapeutics, Inc.
0.7800
+78.08%
TCRX TScan Therapeutics, Inc.
5.27
-1.86%
STTK Shattuck Labs, Inc.
1.2500
-7.41%
ZNTL Zentalis Pharmaceuticals, Inc.
3.2000
+1.91%
MRSN Mersana Therapeutics, Inc.
2.1000
0.00%
SPRB Spruce Biosciences, Inc.
0.5467
+5.68%
IKNA Ikena Oncology, Inc.
1.6900
-1.17%
XBIT XBiotech Inc.
7.57
+0.26%
ORIC ORIC Pharmaceuticals, Inc.
9.12
-3.49%